EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Precision Oncology in Pancreatic Cancer and Future Treatment Directions

Layal Al Mahmasani, Eileen M O'Reilly

Surgical Oncology Clinics of North America · 2026

DOI: 10.1016/j.soc.2025.03.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Surgical Oncology Clinics of North America, 2026. Verfasst von Layal Al Mahmasani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, Office 104, New York, NY 10065, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Precision Medicine, Molecular Targeted Therapy, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: NCI NIH HHS, Memorial Sloan Kettering Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer (PDAC) is one of the most lethal malignancies. The current mainstay therapy for metastatic disease is cytotoxic chemotherapy. The increasing application of molecular profiling and precision oncology plays a significant role in the emergence of investigational targeted therapies. To date, there are a small number of targeted therapies that are FDA-approved and/or endorsed by guidelines. Major emerging targets in PDAC are KRAS, claudin, MTAP, and others. This review provides a brief overview of FDA-approved or guideline-endorsed targeted therapies and summarizes major emerging therapies in the field that are deemed to have high potential to improve outcomes in PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsPrecision MedicineMolecular Targeted TherapyAntineoplastic AgentsHumansBiomarkers, Tumor

Stichwörter der Autor:innen

Clinical trialsMolecular alterationsPancreatic cancerPrecision medicineTargeted therapy

Substanzen

Biomarkers, TumorAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, Office 104, New York, NY 10065, USA.
  • HPB/Neuroendocrine; David M Rubenstein Center for Pancreas Cancer Research, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, Office 104, New York, NY 10065, USA; Weill Medical College at Cornell University,…

Förderung

  • NCI NIH HHS
  • Memorial Sloan Kettering Cancer Center

Zitieren

APA

Al Mahmasani, L., & O'Reilly, E. M. (2026). Precision Oncology in Pancreatic Cancer and Future Treatment Directions. Surgical Oncology Clinics of North America. https://doi.org/10.1016/j.soc.2025.03.002

Vancouver

Al Mahmasani L, O'Reilly EM. Precision Oncology in Pancreatic Cancer and Future Treatment Directions. Surgical Oncology Clinics of North America. 2026. doi:10.1016/j.soc.2025.03.002

BibTeX
@article{AlMahmasani2026,
  author = {Al Mahmasani, Layal and O'Reilly, Eileen M},
  title = {Precision Oncology in Pancreatic Cancer and Future Treatment Directions},
  journal = {Surgical Oncology Clinics of North America},
  year = {2026},
  doi = {10.1016/j.soc.2025.03.002}
}
Kostenlos starten →